Projects awarded funding within the 1st JPIAMR Joint Call

InnovaResistance, published in January 2014, was the first joint transnational call of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) consisting of 19 nations. The call was promoted by 14 funding agencies from 12 countries with a total budget of 13,8M€. “I am very pleased that we now have the first nominated projects within the Joint Programming Initiative on Antimicrobial Resistance,“ said Mats Ulfendahl, chair of the Management Board. The evaluation has been a two-stage process and a peer review panel based on scientific quality evaluated the proposed projects. Based on the recommendation and available funding seven projects have now been nominated for funding. Projects have started at the end of 2014 or beginning of 2015.

Research spotlights from this call:

• NACPLI: Non-conventional approaches for peptidoglycan cross-linking inhibition (pdf 0,2 MB, opens in a new window)
• noTBSec: New intervention strategy for tuberculosis by blocking multiple essential targets (pdf 0,2 MB, opens in a new window)
• SENBIOTAR: Sensitising Pseudomonas aeruginosa biofilms to antibiotic and reducing virulence through novel target inhibition (pdf 0,2 MB, opens in a new window)

Video
We are pleased to share a video, made by the team in the project SENBIOTAR.

Funded projects in this call:

• • • • Non-conventional approaches for peptidoglycan cross-linking inhibition
        Coordinator: Michel Arthur, INSERM, France
        Partners: Waldemar Vollmer, Newcastle Univ, UK
        Tanneke den Blaauwen, Univ of Amsterdam, Netherlands
        Jean-Pierre Simorre, CNRS, France
        John Mc Kinney, Swiss Federal Institute of Technology Lausanne Switzerland
        Natalie Strynadka, Univ of British Columbia, Canada
        Fact sheet on the Project: Non-conventional approaches for peptidoglycan cross-linking inhibition
        
        
      • Sensiting Preudomonas aeruginosa biofilms to antibiotic and reducing virulencec through novel target inhibition
        Coordinator: Miguel Camara, Univ of Nottingham, UK
        Partners: Peter Nielsen, Univ of Copenaghen Denmark
        Roger Levesque, Univ of Laval, Canada Christel Bergström, Uppsala Univ, Sweden
        Fact sheet on the Project: Sensiting Preudomonas aeruginosa biofilms to antibiotic and reducing virulence through novel target inhibition
        
        
      • Repotentiating Beta Lactam antibiotics
        Coordinator: Mariel Pikkemaat, RIKILT-Wageningen UR, as part of stichting DLO, Netherlands
        Partners: Natalie Strynadka, Univ of British Columbia, Canada
        Fredrik Almqvist, Umeå Univ, Sweden
        Fact sheet on the Project: Repotentiating Beta Lactam antibiotics
        
        
      • Structure-guided design of pan inhibitors of metallo-p-lactamases
        Coordinator: Thierry NAAS, Univ Paris Sud, France
        Partners: Youri Glupczynski, CHU Dinant Godinne UCL, Belgium
        Bogdan Iorga, Centre National de la Recherche Scientifique (CNRS) France
        Mariusz Jaskolski, Institute of Bioorganic Chemistry, Polish Academy of Science, Poland
        Fact sheet on the Project: Structure-guided design of pan inhibitors of metallo-p-lactamases
        
        
      • New intervention strategy for tubercolosis: blocking multiple essential targets
        Coordinator: Willbert Bitter, VU Univ Medical center, Netherlands
        Partners: Roland Brosch, Institut Pasteur, France
        Magnus Steigedal, Norwegian Univ of Science and Technology, Norway
        Charles Thompson, Univ of British Columbia, Canada
        Stewart Cole, École polytechnique fédérale de Lausanne, Switzerland
        Fact sheet on the Project: New intervention strategy for tuberculosis: blocking multiple essential targets

• • • Capturing the natural antibiotic´ome: Developing Nature´s EVOLved AntiBIOTIC
      Coordinator: Nathan Magarvey, McMaster Univ, Canada
      Partners: Julian Davies, Univ of British Columbia, Canada
      Eliora Ron, Tel Aviv Univ, Israel
      Raymond Andersen, Univ of British Columbia, Canada
      Jean-Luc Pernodet, Paris-Sud Univ, France
      Gregory Challis, Univ of Warwick, UK
      Fact sheet on the Project: Capturing the natural antibiotic’ome: Developing Nature’s EVOIved AntiBIOTIC Collective
      
      
    • Investigating the Mechanism of Eradication of Multi Drug Resistant Bacteria by Inorganic (mixed metal oxides), Organic (antibiotic) and PROJECT is RELATED to Protein-based Nanoparticles
      Coordinator: Aharon Gedanken, Bar-llan Univ, Israel
      Partners: Horacio Bach, Univ of British Columbia, Canada
      Tzanko Tzanov, Univsitat Politecnica de Calunya, Spain
      EhudBarin, Bar-llan Univ, Israel
      Urs Hafelli, Univ of British Columbia, Canada
      Fact sheet on the Project: Investigating the Mechanism of Eradication of Multi Drug Resistant Bacteria by Inorganic (mixed metal oxides), Organic (antibiotic), and PROJECT is RELATED TO Protein-based Nanoparticles
      

Click on the link below to view more information about the call.
Joint Call “Transnational call InnovaResistance: Innovative approaches to address antibacterial resistance” – call information